NCT04772443View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

PHASE3UnknownINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Dyslipidemias
Interventions
DRUG

DWJ1506

DWJ1506

DRUG

DWJ1507

DWJ1507

DRUG

DWC202011

DWC202011

DRUG

DWJ1177

DWC202011

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT04772443 - Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 | Biotech Hunter | Biotech Hunter